mRNA |
Crizotinib |
FIMM |
pan-cancer |
AAC |
-0.12 |
0.6 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
thapsigargin |
GDSC1000 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
rigosertib |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
Bosutinib |
GDSC1000 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
HBX-41108 |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.6 |
mRNA |
JQ-1:MK-0752 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
fluvastatin |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
TW 37 |
GDSC1000 |
pan-cancer |
AAC |
-0.017 |
0.6 |